Name: RFK Jr.’s Misguided War on mRNA
Uploaded: 2025-08-22T13:57:00Z
Duration: 6 min 52 s
Description: Review & Outlook: Robert F. Kennedy, Jr. is using Biden-era mistakes to tarnish a promising technology, and scientists are pushing back.

https://www.barrons.com/client

Topics

Memberships

Tools

Customer Service

Network

Newsstand

For Business

For Education

For Advertisers

Account

About Barron's

bolded

unBolded

As the budget for government funded agencies such as the NIH and the NSF decline, Josh Wolfe, co-founder and partner of Lux Capital, explains the importance of investing in science and the opportunities.

https://m.wsj.net/video/20250908/f04297d5-2ad0-4876-8c24-a8bc6fb91c57/1/hls/manifest-hd-wifi.m3u8

This Venture Capital Firm Is Creating a ‘Helpline’ For Scientists

"The scale in dollars are huge and the stakes are huge," Josh Wolfe, co-founder and partner of Lux Capital, tells Barron’s Andy Serwer.

https://m.wsj.net/video/20250908/55842143-5877-4e6f-8522-66867235eda6/1/hls/manifest-hd-wifi.m3u8

Where This Venture Capitalist Sees Opportunity in the 'Wild West' of AI

Josh Wolfe, co-founder and partner of Lux Capital, spoke about the state of venture capital today, the areas the firm is investing in, and much more.

https://m.wsj.net/video/20250904/ec13a877-b9b0-4f53-86df-567fce8e471f/1/hls/manifest-hd-wifi.m3u8

A Venture Capitalist on Investing in Science, China, and More

"It is the dominant trend in our industry, and one we are not participating in," Ted Maloney, CEO of MFS Investment Management, tells Barron’s Andy Serwer.

https://m.wsj.net/video/20250827/0af3123b-32e6-40ec-ac1e-18f283763394/1/hls/manifest-hd-wifi.m3u8

Why This Asset Management Company Isn't Leaning Into the Private Space

Ted Maloney, CEO of MFS Investment Management, discusses how policies coming out of Washington are affecting their business strategy today and what kind of policies he’d like to see in the future.

https://m.wsj.net/video/20250827/87b2a785-ecee-4426-b04d-0ae661008afa/1/hls/manifest-hd-wifi.m3u8

This CEO is Hoping for Tax Cuts on Mutual Funds

Ted Maloney, CEO of MFS Investment Management, spoke about active and passive investing, meeting client needs, competitors, and much more.

https://m.wsj.net/video/20250827/0d15d5dc-6778-493a-b3a6-665701f59ac5/1/hls/manifest-hd-wifi.m3u8

'We Are All-In' on Active Investing, MFS CEO Says

Tom Gayner, CEO of Markel Group, tells Barron’s Andy Serwer how the macro environment of the stock market informs his investing strategies.

https://m.wsj.net/video/20250826/c385558f-4d25-4e85-8b13-1a4f7f4bbafb/1/hls/manifest-hd-wifi.m3u8

Bottom-Up Investing in a Top-Down World

Tom Gayner, CEO of Markel Group, spoke about how the holding company has studied Berkshire Hathaway's playbook, Markel's stock performance, and much more.

https://m.wsj.net/video/20250821/28592645-3893-493b-b990-4f1b916795d1/1/hls/manifest-hd-wifi.m3u8

Is this Company a 'Little Berkshire Hathaway'? Its CEO Weighs In.

Betterment CEO Sarah Levy explains how they are incorporating digital currency into their business strategy.

https://m.wsj.net/video/20250815/857ebb79-028b-482a-84d2-18a9c5c2d5bc/1/hls/manifest-hd-wifi.m3u8

Betterment is Dipping Their Toes into Crypto

At Barron's

Saira Malik, chief investment officer of Nuveen, makes the case for more gains in 2023.

https://m.wsj.net/video/20230925/4d8aa5ee-77aa-4400-884b-1fafeff893ec/1/hls/manifest-hd-wifi.m3u8

S&P 4700?

David Bailin, chief investment officer of Citi Global Wealth, offers his take on the latest IPO activity and what it says about the strength of capital markets.

https://m.wsj.net/video/20230925/5f4d4a28-d83a-40e3-ad94-28bc25b1c3bc/1/hls/manifest-hd-wifi.m3u8

IPOs: Making a Comeback

Chris Harvey, head of equity strategy at Wells Fargo Securities, explains what would make him more bullish on stocks and when he sees a Fed rate cut coming.

https://m.wsj.net/video/20230918/1f534ddf-5da9-4d1d-9926-fda63e90468e/1/hls/manifest-hd-wifi.m3u8

Cuts on the Horizon?

Tom Kennedy, chief investment strategist for J.P. Morgan Global Wealth Management, explains why he thinks concerns around a slowdown in China are overblown.

https://m.wsj.net/video/20230918/09304272-5f0c-49df-892a-3a3d4622c9c3/1/hls/manifest-hd-wifi.m3u8

Evaluating China Risk

Liz Young, head of investment strategy at SoFi, discusses how market moving the August inflation data could be.

https://m.wsj.net/video/20230911/50b8c6b4-8fd3-4d6f-adff-dd0a024a57d7/1/hls/manifest-hd-wifi.m3u8

Inflation in the Spotlight

Lindsey Piegza, chief economist at Stifel, offers her take on the biggest risks to the economy right now.

https://m.wsj.net/video/20230911/cac885e4-b322-40f8-876c-ebd443fe9d29/1/hls/manifest-hd-wifi.m3u8

Assessing Economic Headwinds 

Dan Ives, managing director and senior equity analyst at Wedbush Securities, explains why he thinks Apple will continue to be a market leader.

https://m.wsj.net/video/20230905/1a48f030-5a5a-401c-a571-ec9115a0155e/1/hls/manifest-hd-wifi.m3u8

Prove-me Moment

Ross Mayfield, investment strategy analyst at Baird, highlights bullish catalysts that could drive the market higher between now and year-end.

https://m.wsj.net/video/20230905/729974df-4594-4fc6-a385-5457b1d87e32/1/hls/manifest-hd-wifi.m3u8

Gearing up for a Rally

Matthew Luzzetti, chief U.S. economist at Deutsche Bank, discusses what’s next for the Federal Reserve and the economy.

https://m.wsj.net/video/20230501/7264fcc9-eea9-4d99-b839-4cd4c20500c9/1/hls/manifest-hd-wifi.m3u8

Recession Ahead 

MarketBrief | Clips

MarketBrief Clips

David Bailin of Citi Global Wealth and Saira Malik of Nuveen debate the probability of a recession and discuss where they’re finding opportunities in equities and fixed income.

https://m.wsj.net/video/20230925/a61dd831-40b8-4727-934f-077d2b880711/1/hls/manifest-hd-wifi.m3u8

Investing in a Slowing Economy 

Take stock of your investments in less than 10 minutes with new show from Barron’s and MarketWatch.

Chris Harvey of Wells Fargo Securities explains why he believes the Federal Reserve is done hiking interest rates while J.P. Morgan Global Wealth Management’s Tom Kennedy makes the case for multi-asset investing.

https://m.wsj.net/video/20230918/84e9a4a4-4e50-4b7b-934c-9a532f9803fc/1/hls/manifest-hd-wifi.m3u8

Rate Hikes in the Rearview?

Lindsey Piegza of Stifel discusses the upside risks for inflation while SoFi’s Liz Young explains why she’s cautious on the market through year-end.

https://m.wsj.net/video/20230911/395ecb74-e349-45b0-a6b8-f91b8874aaf8/1/hls/manifest-hd-wifi.m3u8

Pricing Pressure & Frothy Valuations

Baird’s Ross Mayfield makes the case for a better than expected September for stocks while Dan Ives of Wedbush Securities explains why big tech can rally another 15%.

https://m.wsj.net/video/20230905/156bf778-e13d-41ef-b750-55e2ef1c0162/1/hls/manifest-hd-wifi.m3u8

September to Remember? 

Kristen Bitterly of Citi Global Wealth Management explains why the strong start to the year is nothing more than a bear market rally while Eric Winograd of AllianceBernstein offers his outlook for the Fed, inflation, and the labor market.

https://m.wsj.net/video/20230220/ae07e591-f017-4e82-babb-c80144e7d42f/1/hls/manifest-hd-wifi.m3u8

Time to be Skeptical?

Anastasia Amoroso of iCapital explains why she thinks the stock market rally is nearing a ceiling while U.S. Bank Wealth Management’s Lisa Erickson discusses where she’s finding investment opportunities in an uncertain environment.

https://m.wsj.net/video/20230213/61be15a3-f5ac-4a25-b944-edd15e605e30/1/hls/manifest-hd-wifi.m3u8

Hitting a Wall

Jack Manley of J.P. Morgan Asset Management explains why now is the time to leg back into risk assets while BlackRock’s Rick Rieder offers his top fixed income opportunities.

https://m.wsj.net/video/20230206/0be0daa9-d29a-4350-b277-a9ee6ed9a2ea/1/hls/manifest-hd-wifi.m3u8

Two Ways to Play

Amid impressive January gains, Cameron Dawson of New Edge Wealth discusses how she’s positioning her portfolio and Mark Zandi of Moody's Analytics explains why he thinks the economy can still avoid a recession.

https://m.wsj.net/video/20230130/a8c37d62-592b-4830-9466-65c3824205fe/1/hls/manifest-hd-wifi.m3u8

Gauging Upside Potential

Mike Schumacher of Wells Fargo Securities explains why he’s nervous about stagflation while Sylvia Jablonski of Defiance Investments offers her top portfolio picks.

https://m.wsj.net/video/20230123/1e752a76-b7d4-4802-821a-837d6176f979/1/hls/manifest-hd-wifi.m3u8

Wall Street’s Biggest Risk

MarketBrief | Full Episodes

MarketBrief Full Episodes

After 10 straight hikes, the central bank switched gears and opted to keep rates steady. But that doesn't mean the Fed's inflation fight is over.

https://m.wsj.net/video/20230616/9dce6e5c-4c62-4aa6-b432-d3407ac41aea/1/hls/manifest-hd-wifi.m3u8

The Fed's Rate Pause, Explained

A publicly traded company can increase it's number of shares available by splitting its stock. Here's why companies may do it and how it affects investors.

https://m.wsj.net/video/20221115/f37dedad-4403-4f6d-bd22-067d0fb148df/1/hls/manifest-hd-wifi.m3u8

Stock Splits Are Big This Year. Here's What They Mean for Investors.

Here's why a publicly traded company may decide to go private and what it means for its shareholders.

https://m.wsj.net/video/20221025/9fb3fa20-e2ac-485b-aa4d-8fcf3ebd3151/1/hls/manifest-hd-wifi.m3u8

What Happens When a Stock Goes Private?

What Happens When a Public Company Goes Private?

When saving for retirement, there are many different accounts and tax strategies to consider. Here's how to tell if a Roth IRA conversion could be right for you.

https://m.wsj.net/video/20221021/624f992c-db58-4144-93cc-b888c6948059/1/hls/manifest-hd-wifi.m3u8

What to Know About Roth IRA Conversions

As recession fears loom, here are three ways investors can prepare and protect their portfolios.

https://m.wsj.net/video/20221020/5d94fa79-7b6d-4c51-8ac7-8c523c99d487/1/hls/manifest-hd-wifi.m3u8

Preparing Your Portfolio for a Recession

Retiring abroad could lower your cost of living, so you can make your savings go further in your golden years. But a permanent move to a new country could be more complicated than you think. Here's what you should know.

https://m.wsj.net/video/20220823/7a028383-44a0-4957-a070-0018f046ec97/1/hls/manifest-hd-wifi.m3u8

Thinking Of Retiring Abroad? Here's What to Consider.

Billionaire-backed space companies have made space tourism a reality. How to participate in a potential private-sector space boom.

https://m.wsj.net/video/20220818/99bac587-9be5-48e6-9376-48f3bb8d55cf/1/hls/manifest-hd-wifi.m3u8

How To Invest In Space Tourism

When you hear the words 'electric vehicle', you might immediately think 'Tesla'. But as more automakers enter the EV competition, Tesla might have trouble holding its lead. Here's what investors need to know.

https://m.wsj.net/video/20220722/111776c7-d9d2-4cd2-8194-4c58b0cb7e57/1/hls/manifest-hd-wifi.m3u8

Is Tesla Miles Ahead of Others in the Electric Vehicle Race?

Chinese tech company DiDi Global, which runs a ride-sharing app, has announced it plans to delist from the New York Stock Exchange. Investors are watching and waiting to see what other Chinese giants with U.S. listings, like Alibaba and JD.com, will do. Here's what delisting entails.

https://m.wsj.net/video/20220722/eacf026e-7303-4eb7-80ab-3e2344e2b120/1/hls/manifest-hd-wifi.m3u8

What Happens When a Stock Delists?

Barron's Explains

Jack talks to Lyft CEO David Risher about the company's turnaround, autonomous driving, and whether they can beat rideshare's biggest company.

https://m.wsj.net/video/20250905/fbe3612b-7cc7-4574-ad67-a7e7de671d0b/1/hls/manifest-hd-wifi.m3u8

Lyft’s Ride to Profit

CEO Cristiano Amon has a plan to shrink Qualcomm’s reliance on phones and grow its role in AI, cars, and beyond. Investors are skeptical—should they be?

https://m.wsj.net/video/20241127/99579ccd-a5c1-4acc-ac31-32469f7d8b1c/1/hls/manifest-hd-wifi.m3u8

What's Next for Qualcomm?

On the Barron's Streetwise Podcast, Barron’s senior writer Al Root sits down with Jack Hough to discuss Toyota’s recent success with hybrids, the coolest cars at the New York Auto Show, and what’s ahead for Tesla stock.

https://m.wsj.net/video/20240329/f163bbd7-0cb6-4c6f-b7f9-a85ae5cd2553/1/hls/manifest-hd-wifi.m3u8

Is Electric Vehicle Demand Cooling Off? 

On the Barron’s Streetwise podcast, Rystad Energy’s Alexandre Ramos Peon discusses how U.S. oil producers have boosted profitability and production despite fewer wells.

https://m.wsj.net/video/20240326/0a4b30c7-379c-460f-abc3-838a7f1eb1a9/1/hls/manifest-hd-wifi.m3u8

The Outlook for Oil

On the Barron’s Streetwise Podcast, Jack Hough pushes back against one of Bitcoin’s most popular valuation models.

https://m.wsj.net/video/20240318/b38cc34a-5064-4a6a-a47c-4c855de11973/1/hls/manifest-hd-wifi.m3u8

Bitcoin as 'Digital Gold' 

On the Barron’s Streetwise podcast, Raphael Zagury of Swan Bitcoin shares his bitcoin price model with Associate Editor Jack Hough.

https://m.wsj.net/video/20240312/c0acb0bf-e4e3-46ca-8fd5-13af6fa401e5/1/hls/manifest-hd-wifi.m3u8

The $600,000 Case for Bitcoin

Kathy Jones, Chief Fixed Income Strategist at Schwab, says it might not matter. Plus, the outlook for yields and the national debt.

https://m.wsj.net/video/20240305/0505813c-e38b-47cb-ade2-e7c3aff68dbd/1/hls/manifest-hd-wifi.m3u8

Bond Funds or Individual Bonds?

Brian Niccol on developing new customer favorites, taking menu tips from TikTok, and the outlook for growing the business.

https://m.wsj.net/video/20230725/dec91556-4dbe-49e6-85d9-ed0e8233ac02/1/hls/manifest-hd-wifi.m3u8

Chipotle's CEO on How He Plans to Double the Business. Again.

Jim Farley on competing with Tesla, and why Ford is favoring Level 3 autonomy over full self-driving capability.

https://m.wsj.net/video/20230519/9aa4288a-39a1-4fb8-8b9d-3be0c58adc18/1/hls/manifest-hd-wifi.m3u8

Ford CEO On the Outlook for EVs and Robo Cars

Barron's Streetwise

Stocks are expensive, risks abound, and AI is about to change the world. Other than that, building a calamity-proof retirement portfolio should be a cinch. Tune in as two veteran money managers size up the markets and share their investment ideas.

https://m.wsj.net/video/20250211/17a5e7d6-7c36-44b0-a35e-bf5ac3a24194/1/hls/manifest-hd-wifi.m3u8

Saving for a Sunny Day

Research shows that people greatly underestimate the healthcare costs they’ll face in retirement. Learn from experts how to estimate those costs, prepare for potential long-term care needs, and manage healthcare expenses in retirement.

https://m.wsj.net/video/20250211/e7c022d9-badf-4e95-8e7c-0b6fce9f7823/1/hls/manifest-hd-wifi.m3u8

Are You Fiscally Fit?

Surging power demand, new energy sources, and growing competition have spurred the utility industry to become more innovative than ever before. Our panelists will unpack the changes afoot and explore what lies ahead for companies, customers, and investors.

https://m.wsj.net/video/20240917/001ea098-1fcc-4da5-9f0e-a3b149bbb2fb/1/hls/manifest-hd-wifi.m3u8

Not Your Father's Utility

Modernizing America's grid will take creativity and money -- lots of money. Learn how players across the power sector can achieve their electrification goals and serve new customers without breaking the bank for consumers.

https://m.wsj.net/video/20240917/bd6bd43a-bb07-4b7f-9d1c-6ae04220bea9/1/hls/manifest-hd-wifi.m3u8

Ready for a Revamp?

The launch this year of Bitcoin ETFs has made it easier for investors to buy and trade the cryptocurrency. But is that a wise move, and if so, how much crypto should you own?

https://m.wsj.net/video/20240529/cbb77f15-ef70-445d-85ae-5f02c24ea1ef/1/hls/manifest-hd-wifi.m3u8

Investing in Cryptocurrencies

Bitcoin and other digital currencies reside on software networks that aim to revolutionize everything from finance to art. Barron's talks to industry experts about the outlook for blockchain technology and its potential uses.

https://m.wsj.net/video/20240529/8f60a5ea-6de4-4c3c-b7c2-12b11aaa99f3/1/hls/manifest-hd-wifi.m3u8

Is Crypto Really a Game-Changer?

Persistent inflation means retirement savings don't go as far as they once did. We discuss the best inflation hedges, and how retirees can benefit from higher-for-longer interest rates.

https://m.wsj.net/video/20240429/69577ad6-cbaf-4d34-96f1-c42136e26aa2/1/hls/manifest-hd-wifi.m3u8

Protecting Your Nest Egg from Rising Prices

The impact of inflation is felt unevenly across the economy and markets. Learn which industries, and companies do best in a “sticky” inflation era, and how fixed income, alternative assets, and gold can help investors hedge against further price growth.

https://m.wsj.net/video/20240429/bfee3cb8-715f-4323-929f-43a73fd58877/1/hls/manifest-hd-wifi.m3u8

Don’t Trim Your Inflation Hedges

Science, tech, and better healthcare delivery are helping people live longer and improving quality of life. Two healthcare investment experts tell us about some of the most promising developments in medicine, and the companies behind them.

https://m.wsj.net/video/20240305/33bed2b1-bdef-401f-bb72-18f7a43f2548/1/hls/manifest-hd-wifi.m3u8

Longevity: An Investor's Playbook

Barron's Roundtable

Barron's Advisor The Way Forward

Investing in Tech

Barron's Investing in Tech Clips

A Better Economy & Wealth Gap Events

Wealth Gap

Level Up

Barron's Events

Back to Business

Great Investors

MarketWatch

Video Center - Barron's home

Review & Outlook: Robert F. Kennedy, Jr. is using Biden-era mistakes to tarnish a promising technology, and scientists are pushing back. Photo: JimWatson/Saul Loeb/AFP/Getty Images/Evan Vucci/AP

https://m.wsj.net/video/20250822/5b6cad19-cd18-4a6f-b276-d048eeb098a6/1/hls/manifest-hd-wifi.m3u8

Review & Outlook: Robert F. Kennedy, Jr. is using Biden-era mistakes to tarnish a promising technology, and scientists are pushing back.

RFK Jr.’s Misguided War on mRNA

Over the past few weeks, BARDA reviewed 22 mRNA vaccine development investments and began canceling them.

Never have I seen a more dangerous approach to responding to our vulnerability to infectious diseases.

HHS has determined that mRNA technology poses more risk than benefits for these respiratory viruses.

It sends a chilling message through the industry and through the scientific establishment in general.

COVID vaccine mandates and a lack of transparency by public health experts produced many unintended effects, but one that continues to gain momentum is a political turn against mRNA technology that could damage US innovation and pandemic preparedness. But before digging in, a brief refresher on messenger ribonucleic acid.

mRNA, it's actually a really ubiquitous compound in our bodies all the time. And really what it is, it's the blueprint that the nucleus, the information center in all of our cells, sends out into the cell to make new proteins.

So every time that a cell wants to make a new protein, as Mr. Ferrari puts it, which is what all cells have to do all of the time in order to carry out functions, it needs to read this blueprint. And crucially, every protein has a different mRNA blueprint.

An mRNA vaccine is a vaccine that carries a little blueprint just for making one protein that is a component of a virus or a bacterium even.

In contrast, we're all familiar with vaccines where we have to inject a little of the virus into our own systems, hopefully not enough to cause problems, but enough that our bodies learn how to react to the different viruses.

Instead of doing that, what we now do is we put the blueprint, we send the blueprint into your body. The blueprint is taken into some of your cells. Your cells manufacture that protein or component of the virus. And only that one tiny piece then is what your body reacts to and generates antibodies to.

Yes, it's true that the Biden administration oversold the ability of the COVID vaccines to provide long-lasting protection against infection.

I really believe this is why God gave us two arms, one for the Flu shot and the other one for the COVID shot.

But real-world evidence did show that they provided strong and relatively durable protection against severe illness. Now to Mr. Kennedy's main issue.

Most of these shots are for flu or COVID. But as the pandemic showed us, mRNA vaccines don't perform well against viruses that infect the upper respiratory tract.

It's an assertion that simply doesn't make sense. No vaccine platform provided long-lasting protection against infection, not just mRNA vaccines. And that's because COVID replicates rapidly in the upper respiratory tract, which makes it difficult for existing vaccines to prevent infections, regardless of whether the virus mutates. But to reiterate, they did provide protection against severe illness. Mr. Kennedy now wants to revert to using decades' old inactivated whole-virus vaccines, which China used during the pandemic. But China's vaccines were less effective than the mRNA shots.

It's not a question of if bird flu will become a pandemic, it's a question of when. Maybe it's not this year, maybe it's not five years from now, maybe it's 10 years from now but we have to be prepared. We have to have technologies in place. And that doesn't mean that everything should be mRNA, that we should only invest into mRNA for the development of vaccines against bird flu. We should be looking at all modalities.

A really critical component of mRNA vaccines is that they're enormously fast to manufacture. And if we see a brand new virus that we've never seen before, we can analyze its DNA or RNA and create the corresponding RNA vaccine way faster and way quicker than we've ever been able to do. And we showed that in 2020 in response to the COVID pandemic.

Writing in "The Washington Post," August 12th, National Institutes of Health director Jay Bhattacharya said he doesn't believe that the mRNA shots have caused mass harm, but that the government is moving away from them because the technology has failed to earn the public's trust, an issue he was vocal about throughout the COVID pandemic.

Essentially, the federal government decided that it knew better than outside scientists what the science about COVID was. And because it wanted to make sure that everyone got the vaccine, they essentially forced social media companies to censor posts.

We're flagging problematic posts for Facebook.

Even true things like, you know, if you had COVID and recovered, that actually gives you pretty good immunity.

So how does Mr. Kennedy saying mRNA poses more risks than benefits restore public trust? Surely blackballing mRNA will simply increase skepticism of a technology that has real potential.

The use of mRNA in vaccinations and in treatment of cancer and rare genetic disorders is something that this collection of thousands of the world's experts believes strongly in.

The Moderna vaccine has officially entered phase three already.

And we really do appreciate the leadership of the president during his first administration to show that this technology was something that the world really needed to see.

So while it was the Trump administration's Operation Warp Speed that demonstrated America's ingenuity with mRNA technology, it's Team Trump's Health Secretary that's now throwing it all away, all the while admitting that it has shown positive results on other conditions.

For some illnesses, mRNA vaccines may be very useful and that would include cancers.

And the truth is that there are other countries around the world, you know, including China, as well as Europe and Asia in general that are not throwing away their investment into mRNA research and mRNA vaccine development. In fact, they're doubling down. And if we don't reverse these decisions soon, then we'll be watching other countries achieve innovation in this space, and have life-saving medicines that we simply don't have access to.

WSJ Opinion: RFK Jr.’s Misguided War on mRNA

Videos that speak for free markets and free people, the principles, if you will, marked in the watershed year of 1776 by Thomas Jefferson's Declaration of Independence and Adam Smith's "Wealth of Nations."  

WSJ Opinion: RFK Jr.’s Misguided War on mRNA

Review and Outlook by The Editorial Board

Up Next

At Barron's

View All

MarketBrief Clips

View All

MarketBrief Full Episodes

View All

Barron's Explains

View All

Barron's Streetwise

View All

Barron's Roundtable

View All

Barron's Investing in Tech Clips

View All

Wealth Gap

View All

Level Up

View All

Barron's Events

View All

Back to Business

View All

Great Investors

View All

MarketWatch

View All